Preoperative Decision to Perform Portal Vein Resection Improves Survival in Patients With Resectable Pancreatic Head Cancer Adjacent to Portal Vein.
Journal
Annals of surgery open : perspectives of surgical history, education, and clinical approaches
ISSN: 2691-3593
Titre abrégé: Ann Surg Open
Pays: United States
ID NLM: 101769928
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
21
03
2021
accepted:
28
03
2021
medline:
5
5
2021
pubmed:
5
5
2021
entrez:
28
8
2023
Statut:
epublish
Résumé
We hypothesized that preoperatively planned portal vein resection (PVR), which prevents from approaching tumors, improves survival in patients with resectable pancreatic head cancer adjacent to the portal vein (PhC-PV). The decision to perform PVR is difficult in patients with resectable PhC-PV. This is a retrospective, bi-institutional study of patients undergoing pancreatoduodenectomy (PD) for resectable PhC-PV from 2009 to 2018. We compared clinical data of patients who underwent PD with preoperatively planned PVR (planned PVR group) and those who underwent conventional PD (cPD) in which decision to perform PVR was made intraoperatively (cPD group). Among the study population of 176 patients, 53 patients (30.1%) underwent PD with planned PVR. The remaining 123 patients (69.9%) underwent cPD. Tumor characteristics were similar between the 2 groups. Operation time and major complication rates did not differ between the 2 groups. The local recurrence rate of patients in the planned PVR group (28.3%) was lower than that of the cPD group (44.7%; The preoperative decision to perform PVR improves survival by enhancing local control of resectable PhC-PV.
Identifiants
pubmed: 37636553
doi: 10.1097/AS9.0000000000000064
pmc: PMC10455064
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e064Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
Disclosure: The authors declare that they have nothing to disclose.
Références
Ann Surg. 1977 Jul;186(1):42-50
pubmed: 195543
Surgery. 1951 Sep;30(3):550-3
pubmed: 14866700
Br J Surg. 2015 Jun;102(7):837-46
pubmed: 25877050
Br J Surg. 2013 Sep;100(10):1349-56
pubmed: 23939847
Surgery. 2016 Mar;159(3):872-7
pubmed: 26603847
BJS Open. 2020 Jun;4(3):438-448
pubmed: 32191395
J Gastrointest Surg. 2010 Sep;14(9):1442-52
pubmed: 20379794
J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210
pubmed: 30865919
Br J Surg. 2017 Oct;104(11):1539-1548
pubmed: 28833055
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur J Surg Oncol. 2012 Apr;38(4):340-5
pubmed: 22264964
Ann Surg. 2015 Dec;262(6):1092-101
pubmed: 25587814
J Am Coll Surg. 2014 Mar;218(3):401-11
pubmed: 24484730
Ann Surg Oncol. 2009 Apr;16(4):817-25
pubmed: 19156463
Eur J Surg Oncol. 2012 Jan;38(1):72-9
pubmed: 22054617
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
World J Surg. 2010 Dec;34(12):2939-44
pubmed: 20703458
Ann Surg. 1996 Sep;224(3):342-7; discussion 347-9
pubmed: 8813262
JOP. 2010 May 05;11(3):230-3
pubmed: 20442517
Ann Surg. 2015 Dec;262(6):1071-8
pubmed: 25590497
J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50
pubmed: 15585381
Ann Surg. 2022 May 1;275(5):962-971
pubmed: 32649469
BJS Open. 2019 Jan 24;3(3):327-335
pubmed: 31183449
Ann Surg. 2017 Mar;265(3):565-573
pubmed: 27918310
Surgery. 2012 Sep;152(3 Suppl 1):S43-9
pubmed: 22763261